$7.99
-0.08-0.99%
At Close: -
$8.07
0.081.00%
After Hours: Jul 2, 4:00 PM EDT
15 minutes delayed
INmune Bio
INMBNASDAQ
INmune Bio (NASDAQ:INMB) Stock Quotes, Forecast and News Summary
INmune Bio Stock (NASDAQ: INMB) stock price, news, charts, stock research, profile.
| Open | $8.20 |
| Close | $7.99 |
| Volume / Avg. | 112.15K / 167.47K |
| Day Range | 7.80 - 8.20 |
| 52 Wk Range | 6.50 - 14.74 |
| Market Cap | $159.64M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 42 |
| Short Interest | 13.03% |
| Days to Cover | 23.53 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About INmune Bio Inc
Sector
Health Care
Industry
Biotechnology
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new im...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy INmune Bio (INMB) stock?
You can purchase shares of INmune Bio (NASDAQ:INMB) through any online brokerage.
Who are INmune Bio (INMB) competitors?
Other companies in INmune Bio’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), bluebird bio (NASDAQ:BLUE), Atossa Therapeutics (NASDAQ:ATOS) and Opthea (NASDAQ:OPT).
What is the target price for INmune Bio (INMB) stock?
There is no analysis for INmune Bio.
What is the forecast for INmune Bio (INMB) stock?
INmune Bio has a consensus price target of $12.33.
Current stock price for INmune Bio (INMB)?
The stock price for INmune Bio (NASDAQ: INMB) is $8.07 last updated July 2, 2024 at 4:00 PM EDT.
Does INmune Bio (INMB) pay a dividend?
There are no upcoming dividends for INmune Bio.
When is INmune Bio (NASDAQ:INMB) reporting earnings?
INmune Bio’s Q2 earnings are confirmed for Monday, August 5, 2024.
Is INmune Bio (INMB) going to split?
There is no upcoming split for INmune Bio.
What sector and industry does INmune Bio (INMB) operate in?
INmune Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.